Dr. Sara Naseri - Biomarkers in Menstrual Blood, the Women's Health Movement & Breaking Stigma in Science

Can menstrual blood become the ultimate biohacking tool for women?

Meet Dr. Sara Naseri, the co-founder and CEO of Qvin. This year Qvin got FDA approval for the first even diagnostic menstrual pad, proving that menstrual blood has tremendous medical utility. Today, women in the US can already order the Q-pad to test their blood glucose levels. This is just the beginning. Qvin is already working on more biomarkers and insights, including cervical cancer screening.

Enjoy!

Want to become a MOTHER-sponsor and create some magic together? Reach out to us: https://shorturl.at/0RHLM

(0:00) Intro

(4:40) How a forensic investigation led to breakthrough research on menstrual blood

(6:10) What’s inside period blood and why it matters

(7:36) The presence of stem cells in the endometrium

(8:58) Insights we can gain from analyzing menstrual blood

(10:30) Using menstrual blood to detect cervical cancer

(12:30) How the Q-pad works and conditions it can diagnose

(16:50) Making healthcare more accessible around the world through menstrual blood analysis

(18:10) How menstrual blood is changing our understanding of female biology

(22:37) The presence of inflammation markers in menstrual blood

(24:00) Menstrual blood’s role in diagnosing endometriosis

(26:57) The stigma around menstrual blood in the scientific community

(30:10) Menstrual blood as a biohacking tool for women

(31:50) How environmental factors affect menstrual blood and women's health

(32:58) The potential of menstrual blood to reveal nutritional deficiencies and hormonal imbalances

(36:00) The future of menstrual blood research and women's health

Links:

Qvin - https://qvin.com/ and @weareqvin on socials

Sara's LinkedIn - https://www.linkedin.com/in/naseri/

Hosted on Acast. See acast.com/privacy for more information.